[DPHARMA] QoQ TTM Result on 30-Sep-2011 [#3]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
21-Nov-2011
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2011
Quarter
30-Sep-2011 [#3]
Profit Trend
QoQ- -0.34%
YoY- 3.91%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
TTM Result
30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 CAGR
Revenue 140,215 141,205 138,132 137,291 134,988 135,625 131,437 4.40%
PBT 35,468 35,723 34,729 35,500 35,995 36,493 35,410 0.10%
Tax -8,043 -8,233 -8,023 -6,509 -6,906 -7,030 -6,741 12.50%
NP 27,425 27,490 26,706 28,991 29,089 29,463 28,669 -2.91%
-
NP to SH 27,425 27,490 26,706 28,991 29,089 29,463 28,669 -2.91%
-
Tax Rate 22.68% 23.05% 23.10% 18.34% 19.19% 19.26% 19.04% -
Total Cost 112,790 113,715 111,426 108,300 105,899 106,162 102,768 6.40%
-
Net Worth 162,310 170,824 163,776 162,353 154,198 162,320 156,744 2.35%
Dividend
30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 CAGR
Div 24,980 24,987 24,987 5,014 5,014 6,402 6,402 148.05%
Div Payout % 91.09% 90.90% 93.56% 17.30% 17.24% 21.73% 22.33% -
Equity
30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 CAGR
Net Worth 162,310 170,824 163,776 162,353 154,198 162,320 156,744 2.35%
NOSH 138,727 138,881 138,793 138,763 138,917 138,735 138,711 0.00%
Ratio Analysis
30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 CAGR
NP Margin 19.56% 19.47% 19.33% 21.12% 21.55% 21.72% 21.81% -
ROE 16.90% 16.09% 16.31% 17.86% 18.86% 18.15% 18.29% -
Per Share
30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 CAGR
RPS 101.07 101.67 99.52 98.94 97.17 97.76 94.76 4.39%
EPS 19.77 19.79 19.24 20.89 20.94 21.24 20.67 -2.92%
DPS 18.00 18.00 18.00 3.61 3.61 4.61 4.61 148.16%
NAPS 1.17 1.23 1.18 1.17 1.11 1.17 1.13 2.34%
Adjusted Per Share Value based on latest NOSH - 138,763
30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 CAGR
RPS 14.58 14.68 14.36 14.27 14.03 14.10 13.66 4.44%
EPS 2.85 2.86 2.78 3.01 3.02 3.06 2.98 -2.93%
DPS 2.60 2.60 2.60 0.52 0.52 0.67 0.67 147.14%
NAPS 0.1687 0.1776 0.1703 0.1688 0.1603 0.1687 0.1629 2.36%
Price Multiplier on Financial Quarter End Date
30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 CAGR
Date 29/06/12 30/03/12 30/12/11 30/09/11 30/06/11 31/03/11 30/12/10 -
Price 2.23 2.40 2.02 2.10 2.34 2.35 2.39 -
P/RPS 2.21 2.36 2.03 2.12 2.41 2.40 2.52 -8.38%
P/EPS 11.28 12.13 10.50 10.05 11.17 11.07 11.56 -1.62%
EY 8.87 8.25 9.53 9.95 8.95 9.04 8.65 1.69%
DY 8.07 7.50 8.91 1.72 1.54 1.96 1.93 159.77%
P/NAPS 1.91 1.95 1.71 1.79 2.11 2.01 2.12 -6.72%
Price Multiplier on Announcement Date
30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 CAGR
Date 16/08/12 17/05/12 22/02/12 21/11/11 18/08/11 25/05/11 23/02/11 -
Price 2.38 2.38 2.12 2.10 2.22 2.57 2.45 -
P/RPS 2.35 2.34 2.13 2.12 2.28 2.63 2.59 -6.28%
P/EPS 12.04 12.02 11.02 10.05 10.60 12.10 11.85 1.06%
EY 8.31 8.32 9.08 9.95 9.43 8.26 8.44 -1.03%
DY 7.56 7.56 8.49 1.72 1.63 1.79 1.88 153.09%
P/NAPS 2.03 1.93 1.80 1.79 2.00 2.20 2.17 -4.35%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment